Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Over 1,800 studies performed across Phase I–III, including bioavailability, pharmacokinetic, NDA-enabling, and first-in-human trials, with data supporting over 60 successful new drug applications. Notable expertise in special population studies (renal/hepatic impairment, diabetes, obesity) and early-phase safety/PK studies
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinical Pharmacology of Miami.